Turkish Validity and Reliability of Physiotherapist Self-Efficacy Questionnaire

November 3, 2022 updated by: Cigdem Emirza, Istanbul Bilgi University

Turkish Validity and Reliability Study of Physiotherapist Self-Efficacy Questionnaire

The aim of this study is to provide Turkish validation and determine the validity of the "Physiotherapist Self-Efficacy Questionnaire".

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Self-efficacy is defined as one's belief in one's existing capacity to perform the necessary behavior in a specific situation. "Physiotherapist Self-Efficacy Questionnaire" has been developed to be used in the assessment of self-efficacy for the field of physiotherapy and rehabilitation. In this scale, there are 13 items about how competent the individual feels in clinical assessment, problem solving, planning, and communication related to caseloads.

It has been shown that the scale is a valid and reliable method in cardiorespiratory, musculoskeletal and neurological clinical fields, which are special areas of physiotherapy and rehabilitation.

Study Type

Observational

Enrollment (Actual)

122

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Istanbul, Turkey
        • Istanbul Bilgi University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

The physiotherapy and rehabilitation students who have done internship in at least one institution or graduate physiotherapists will be included in the study. Participants will re-answer the Turkish version of Physiotherapist Self-Efficacy Questionnaire within one week. They will also answer the General Self-efficacy Scale.

Description

Inclusion Criteria:

  • Able to speak, read, understand and write in Turkish
  • Physiotherapy and rehabilitation students who have participated in at least one clinical practice
  • Physiotherapists working in the clinic

Exclusion Criteria:

  • Having cognitive problems

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Group I
Other: Questionnaire study
The Turkish validity and reliability of the questionnaire will be examined.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Turkish version of Physiotherapist Self-Efficacy Questionnaire-cardiorespiratory area
Time Frame: Baseline and after one week
The questionnaire consists of 13 items. The participants will asked to indicate their confidence to perform the described task (1 = very little confidence; 5 = a lot of confidence). Higher scores are related more confidence self-efficacy.
Baseline and after one week
Turkish version of Physiotherapist Self-Efficacy Questionnaire-musculoskeletal area
Time Frame: Baseline and after one week
The questionnaire consists of 13 items. The participants will asked to indicate their confidence to perform the described task (1 = very little confidence; 5 = a lot of confidence). Higher scores are related more confidence self-efficacy.
Baseline and after one week
Turkish version of Physiotherapist Self-Efficacy Questionnaire-neurological area
Time Frame: Baseline and after one week
The questionnaire consists of 13 items. The participants will asked to indicate their confidence to perform the described task (1 = very little confidence; 5 = a lot of confidence). Higher scores are related more confidence self-efficacy.
Baseline and after one week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
General Self-Efficacy Scale
Time Frame: Baseline
This scale consists of 10 items. The answers are in a four-likert form (completely true, somewhat true, moderately accurate, completely wrong).
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Istanbul Bilgi University

Investigators

  • Principal Investigator: Aycan Cakmak Reyhan, PT, phD, Istanbul Bilgi University
  • Principal Investigator: Tugba Kuru Colak, PT, phD, Marmara University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 6, 2022

Primary Completion (Actual)

October 24, 2022

Study Completion (Actual)

November 3, 2022

Study Registration Dates

First Submitted

April 6, 2022

First Submitted That Met QC Criteria

April 12, 2022

First Posted (Actual)

April 19, 2022

Study Record Updates

Last Update Posted (Actual)

November 4, 2022

Last Update Submitted That Met QC Criteria

November 3, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 20022-40030-32

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Education

Clinical Trials on Questionnaire study

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Peru

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe